Loading clinical trials...
Loading clinical trials...
Background: One in ten people infected with COVID-19 presents persistent COVID, which consists of the presence of symptoms three months after the acute manifestations of COVID-19 and their persistence...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Corporacion Parc Tauli
Collaborators
NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more
NCT06095297 · Long COVID, Brain Fog, and more
NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more
NCT06932237 · Neuro-PASC, Long COVID
NCT06721949 · Long COVID
Corporació Sanitària Parc Taulí
Sabadell, Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions